Disruption of IRE1α through its kinase domain attenuates multiple myeloma
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Significance: Multiple myeloma (MM) is a lethal malignancy arising from plasma cells. MM cells experience endoplasmic reticulum (ER) stress due to immunoglobulin hyperproduction. The ER-resident sensor IRE1α mitigates ER stress by expanding protein-folding and secretion capacity, while supporting proteasomal degradation of ER misfolded proteins. IRE1α elaborates these functions by deploying a cytoplasmic kinase–RNase module to activate the transcription factor XBP1s. Although IRE1α has been implicated in MM, its validity as a potential therapeutic target—particularly as a kinase—has been unclear. Using genetic and pharmacologic disruption, we demonstrate that the IRE1α–XBP1s pathway is critical for MM tumor growth. We further show that the kinase domain of IRE1α is an effective and safe potential small-molecule target for MM therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IRE1α inhibitors KIRA8 or AMG‐18, STF083010, MKC8866 and MKC3946 reduced tumor growth in various cancers, including multiple myeloma [185, 186, 187], melanoma [188], breast cancer and prostate cancer [189].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [185]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924
Self-citationThe unfolded protein response: controlling cell fate decisions under ER stress and beyond
Hetz, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3270 · Cited by 4,093
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., & Ron, D. (2000) · Science · doi:10.1126/science.287.5453.664 · Cited by 2,988
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Tabas, I., & Ron, D. (2011) · Nature Cell Biology · doi:10.1038/ncb0311-184 · Cited by 2,598
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S., & Walter, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80835-1 · Cited by 1,992
Self-citationProtein misfolding in the endoplasmic reticulum as a conduit to human disease
Wang, M., & Kaufman, R. J. (2016) · Nature · doi:10.1038/nature17041 · Cited by 1,630
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
Lu, G., Middleton, R. E., Sun, H., Naniong, M., Ott, C. J., Mitsiades, C. S., Wong, K.-K., Bradner, J. E., & Kaelin, W. G. (2014) · Science · doi:10.1126/science.1244917 · Cited by 1,583
Cited by
Endoplasmic reticulum stress signals in the tumour and its microenvironment
Chen, X., & Cubillos-Ruiz, J. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00312-2 · Cited by 1,356
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
Endoplasmic Reticulum Stress Signaling in Cancer Cells
Oakes, S. A. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.01.010 · Cited by 397
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate
Siwecka, N., Rozpędek-Kamińska, W., Wawrzynkiewicz, A., Pytel, D., Diehl, J. A., & Majsterek, I. (2021) · Biomedicines · doi:10.3390/biomedicines9020156 · Cited by 172
Metadata
- Authors
- Harnoss, J. M., Le Thomas, A., Shemorry, A., Marsters, S. A., Lawrence, D. A., Lu, M., Chen, Y.-C. A., Qing, J., Totpal, K., Kan, D., Segal, E., Merchant, M., Reichelt, M., Ackerly Wallweber, H., Wang, W., Clark, K., Kaufman, S., Beresini, M. H., Laing, S. T., Sandoval, W., Lorenzo, M., Wu, J., Ly, J., De Bruyn, T., Heidersbach, A., Haley, B., Gogineni, A., Weimer, R. M., Lee, D., Braun, M.-G., Rudolph, J., VanWyngarden, M. J., Sherbenou, D. W., Gomez-Bougie, P., Amiot, M., Acosta-Alvear, D., Walter, P., & Ashkenazi, A.
- Affiliations
- Genentech (US)
- Cancer Immunology, Genentech, Inc., South San Francisco, CA 94080;
- Translational Oncology, Genentech, Inc., South San Francisco, CA 94080;
- Structural Biology, Genentech, Inc., South San Francisco, CA 94080;
- Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080;
- University of Colorado Cancer Center (US)
- Centre de Recherche en Cancérologie et Immunologie Nantes-Angers, INSERM, CNRS, Université d’Angers, Université de Nantes, BP 70721 Nantes, France;
- Centre National de la Recherche Scientifique (FR)
- Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143;
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ashkenazi, Avi
- ORCID
- Harnoss, Jonathan M.
- Shemorry, Anna
- Marsters, Scot A.
- Lawrence, David A.
- Lu, Min
- Kan, David
- Merchant, Mark
- Reichelt, Mike
- Wang, Weiru
- Clark, Kevin
- Laing, Steven T.
- Sandoval, Wendy
- Heidersbach, Amy
- Haley, Benjamin
- Gogineni, Alvin
- Weimer, Robby M.
- Lee, Dong
- Braun, Marie-Gabrielle
- Rudolph, Joachim
- VanWyngarden, Michael J.
- Sherbenou, Daniel W.
- Amiot, Martine
- Acosta-Alvear, Diego
- Walter, Peter
- Ashkenazi, Avi
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-08
- Volume
- 116
- Issue
- 33
- Pages
- 16420-16429
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6697881
- OpenAlex
- W2964798481
- Cited by
- 109
- References
- 52
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 8 · 2023: 15 · 2022: 13 · 2021: 22 · 2020: 21 · 2019: 3
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- Howard Hughes Medical Institute (HHMI Collaborative Innovation Award, HHMI Investigator Award)
- Cancer Research Institute (Irvington Postdoctoral Fellowship)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- multiple myeloma, IRE1α, endoplasmic reticulum stress, XBP1, unfolded protein response, plasma cells, small-molecule kinase inhibitors, therapeutic target
- MeSH terms
- Bortezomib, X-Box Binding Protein 1, Lenalidomide, Aged, Animals, Endoribonucleases, Female, Humans, Male, Middle Aged, Multiple Myeloma, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Xenograft Model Antitumor Assays, Protein Kinase Inhibitors, Mice, Unfolded Protein Response, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disruption of IRE1α through its kinase domain attenuates multiple myeloma. https://app.cochat.ai/papers/10.1073/pnas.1906999116
- The paper
- Harnoss, J. M., Le Thomas, A., Shemorry, A., Marsters, S. A., Lawrence, D. A., Lu, M., Chen, Y.-C. A., Qing, J., Totpal, K., Kan, D., Segal, E., Merchant, M., Reichelt, M., Ackerly Wallweber, H., Wang, W., Clark, K., Kaufman, S., Beresini, M. H., Laing, S. T., . . . Ashkenazi, A. (2019). Disruption of IRE1α through its kinase domain attenuates multiple myeloma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1906999116
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.